Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Programming

Health care delivery (1)

Filter by Specific Population

Filter by Topic

Filter by Infection

HIV (remove)
Hepatitis C (1)

Filter by Resource Category

Search results

Current filters: HIV, Treatment, HIV drugs

164 search results

1
2
3
4
5

Biktarvy: 2018, CATIE
Fact sheet - Webpage
Isentress HD (raltegravir once daily): 2018, CATIE
Fact sheet - Webpage
Symtuza: 2018, CATIE
Fact sheet - Webpage
Juluca: 2018, CATIE
Fact sheet - Webpage
Isentress (raltegravir twice daily): 2018, CATIE
Fact sheet - Webpage
Italian study explores dual drug regimens as maintenance treatment: From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage
Dual maintenance therapy with dolutegravir + rilpivirine: From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage
Dolutegravir + 3TC for the initial treatment of HIV: From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage
Delstrigo approved in Canada for HIV treatment: 2018, CATIE
Research summary - Webpage
Doravirine (Pifeltro) approved in Canada for HIV treatment: 2018, CATIE
Research summary - Webpage

1
2
3
4
5

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.